Quadrivalent Market Report 2024: Strategies And Recent Developments | AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2635

The Business Research Company offers in-depth market insights through Quadrivalent Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The quadrivalent market size has grown strongly in recent years. It will grow from $8.28 billion in 2023 to $8.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to disease complexity, educational initiatives, past health events, healthcare growth, technological progress..

The quadrivalent market size is expected to see strong growth in the next few years. It will grow to $12.88 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to global health events, competitive dynamics, educational campaigns, regulatory changes, evolving disease patterns.. Major trends in the forecast period include disease prevalence, regulatory environment, healthcare infrastructure, consumer awareness and education, competitive landscape..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Market Segmentation:
The quadrivalent market covered in this report is segmented -

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Major Driver - Quadrivalent Vaccines Is A Crucial Strategy In Combating The Dual Burden Of Chronic And Infectious Diseases
The rising prevalence of chronic and infectious diseases is expected to propel the growth of the quadrivalent market moving forward. A chronic disease is a long-term sickness caused by genetics and lifestyle, whereas an infectious disease is any ailment caused by an infectious agent such as a virus, bacteria, fungus, or protozoan. Quadrivalent vaccines have a significant impact in preventing morbidity and mortality from serious infections, as well as diseases other than the specific infections they are designed to target. Quadrivalent vaccines are being used to prevent chronic (non-communicable) diseases when infectious agents are involved in carcinogenesis. For instance, in September 2022, according to the World Health Organization, a Switzerland-based agency responsible for international public health, every year, 17 million people die from a chronic or noncommunicable disease (NCD) before the age of 70. Furthermore, in 2021, there were estimated 247 million cases of malaria (an infectious disease) globally, with an estimated 619,000 fatalities. Therefore, the rising prevalence of chronic and infectious diseases is driving the growth of the quadrivalent market.

Competitive Landscape:
Major companies operating in the quadrivalent market report are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Xenetic Biosciences Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., Biodiem Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., MedImmune, Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG) .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Top Trend - Innovative Strides In Influenza Vaccination Through Astrazeneca's Launch Of Flumist Quadrivalent
Product innovations are a key trend gaining popularity in the quadrivalent market. Major companies operating in the quadrivalent market are focused on developing innovative solutions to strengthen their position in the market. For instance, in September 2022, AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal), a Food and Drug Administration (FDA)-approved nasal-spray flu vaccine for persons aged 2 to 49, that can be administered through a needle-free nasal spray. It is a live attenuated influenza vaccine (LAIV), available in trivalent or quadrivalent formulations, and is covered by most health insurance plans as well as the vaccines for children program.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Quadrivalent Market Characteristics
3. Quadrivalent Market Trends And Strategies
4. Quadrivalent Market - Macro Economic Scenario
5. Quadrivalent Market Size And Growth
…..
27. Quadrivalent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.